# Shilpa Pharma Lifesciences Limited – FDA Inspection, Jul 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/83adb497-fdf6-4c23-97c3-387b0f981a9a
Source feed: FDA_Inspections

> FDA inspection 1099290 of Shilpa Pharma Lifesciences Limited, July 26, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099290
- Company Name: Shilpa Pharma Lifesciences Limited
- Inspection Date: 2019-07-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1268017 - 2025-03-14](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/c05f8235-07b2-49d6-ae5a-564fd3035628)
- FDA Inspection 1122653 - 2020-02-07
- [FDA Inspection 1038233 - 2018-01-19](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/6bcbf041-9fbc-4e76-b011-554b86ed00f9)
- [FDA Inspection 1004337 - 2016-12-16](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/5d720105-ac3e-4242-8ae2-84a3f0c57bb6)
- FDA Inspection 926998 - 2015-03-09

## Related Officers

- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)

Company: https://www.keypedia.com/companies/shilpa-pharma-lifesciences-limited/4f617c67-eea7-483d-b9c7-b1dd31aabcff

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c